Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development.
There is a paucity of longitudinal data on the serotype-specific burden of invasive group B Streptococcus (GBS) disease from low-middle income countries, which could inform selection of vaccine epitopes.From 2005 to 2014, infants less than 90 days of age with invasive GBS disease were identified thr...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5201280?pdf=render |
id |
doaj-10aa4282254e4d0588559a1d5341e641 |
---|---|
record_format |
Article |
spelling |
doaj-10aa4282254e4d0588559a1d5341e6412020-11-25T01:32:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011112e016910110.1371/journal.pone.0169101Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development.Ziyaad DangorClare L CutlandAlane IzuGaurav KwatraSiobhan TrenorSanjay G LalaShabir A MadhiThere is a paucity of longitudinal data on the serotype-specific burden of invasive group B Streptococcus (GBS) disease from low-middle income countries, which could inform selection of vaccine epitopes.From 2005 to 2014, infants less than 90 days of age with invasive GBS disease were identified through sentinel laboratory and hospital admission surveillance at Chris Hani Baragwanath Academic Hospital in Soweto, South Africa.We identified 820 cases of invasive GBS disease, including 55% among newborns <7 days age (i.e. early-onset disease; EOD). The overall incidence (per 1,000 live births) of invasive GBS disease was 2.59 (95% CI: 2.42-2.77), including 1.41 (95% CI: 1.28-1.55) for EOD and 1.18 (95% CI: 1.06-1.30) in infants 7-89 days age (late-onset disease). Year-on-year, from 2005 to 2014, we observed a 9.4% increase in incidence of serotype Ia invasive disease (RR: 1.09; 95% CI: 1.04-1.15; p<0.001), and a 7.4% decline in serotype III invasive disease (RR: 0.93; 95% CI: 0.90-0.96; p<0.001). Overall, serotypes Ia (28.2%), III (55.4%) and V (7.9%) were the commonest disease causing serotypes.The incidence of invasive GBS disease has remained persistently high in our setting, with some changes in serotype distribution, albeit mainly involving the same group of dominant serotypes.http://europepmc.org/articles/PMC5201280?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ziyaad Dangor Clare L Cutland Alane Izu Gaurav Kwatra Siobhan Trenor Sanjay G Lala Shabir A Madhi |
spellingShingle |
Ziyaad Dangor Clare L Cutland Alane Izu Gaurav Kwatra Siobhan Trenor Sanjay G Lala Shabir A Madhi Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development. PLoS ONE |
author_facet |
Ziyaad Dangor Clare L Cutland Alane Izu Gaurav Kwatra Siobhan Trenor Sanjay G Lala Shabir A Madhi |
author_sort |
Ziyaad Dangor |
title |
Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development. |
title_short |
Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development. |
title_full |
Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development. |
title_fullStr |
Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development. |
title_full_unstemmed |
Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development. |
title_sort |
temporal changes in invasive group b streptococcus serotypes: implications for vaccine development. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2016-01-01 |
description |
There is a paucity of longitudinal data on the serotype-specific burden of invasive group B Streptococcus (GBS) disease from low-middle income countries, which could inform selection of vaccine epitopes.From 2005 to 2014, infants less than 90 days of age with invasive GBS disease were identified through sentinel laboratory and hospital admission surveillance at Chris Hani Baragwanath Academic Hospital in Soweto, South Africa.We identified 820 cases of invasive GBS disease, including 55% among newborns <7 days age (i.e. early-onset disease; EOD). The overall incidence (per 1,000 live births) of invasive GBS disease was 2.59 (95% CI: 2.42-2.77), including 1.41 (95% CI: 1.28-1.55) for EOD and 1.18 (95% CI: 1.06-1.30) in infants 7-89 days age (late-onset disease). Year-on-year, from 2005 to 2014, we observed a 9.4% increase in incidence of serotype Ia invasive disease (RR: 1.09; 95% CI: 1.04-1.15; p<0.001), and a 7.4% decline in serotype III invasive disease (RR: 0.93; 95% CI: 0.90-0.96; p<0.001). Overall, serotypes Ia (28.2%), III (55.4%) and V (7.9%) were the commonest disease causing serotypes.The incidence of invasive GBS disease has remained persistently high in our setting, with some changes in serotype distribution, albeit mainly involving the same group of dominant serotypes. |
url |
http://europepmc.org/articles/PMC5201280?pdf=render |
work_keys_str_mv |
AT ziyaaddangor temporalchangesininvasivegroupbstreptococcusserotypesimplicationsforvaccinedevelopment AT clarelcutland temporalchangesininvasivegroupbstreptococcusserotypesimplicationsforvaccinedevelopment AT alaneizu temporalchangesininvasivegroupbstreptococcusserotypesimplicationsforvaccinedevelopment AT gauravkwatra temporalchangesininvasivegroupbstreptococcusserotypesimplicationsforvaccinedevelopment AT siobhantrenor temporalchangesininvasivegroupbstreptococcusserotypesimplicationsforvaccinedevelopment AT sanjayglala temporalchangesininvasivegroupbstreptococcusserotypesimplicationsforvaccinedevelopment AT shabiramadhi temporalchangesininvasivegroupbstreptococcusserotypesimplicationsforvaccinedevelopment |
_version_ |
1725079576777850880 |